2025 PACC Miami | FOLFOX + Atezolizumab, Retifanlimab, Zolbetuximab, PIK3CA & Aspirin; Time to Catch-Up with Recent Advancements in the Management in Gastro-Intestinal Malignancies

2025 PACC Miami | FOLFOX + Atezolizumab, Retifanlimab, Zolbetuximab, PIK3CA & Aspirin; Time to Catch-Up with Recent Advancements in the Management in Gastro-Intestinal Malignancies

0% Complete

Course Content

FOLFOX + Atezolizumab, Retifanlimab, Zolbetuximab, PIK3CA & Aspirin; Time to Catch-Up with Recent Advancements in the Management in Gastro-Intestinal Malignancies

Credits

  • AMA PRA Category 1 Credit™Non-CME

Course Details

Duration
0.00 hour
Released
Nov 23, 2025
Last Review
Nov 23, 2025
Expires
Nov 23, 2026

Target Audience

Pharmacists

Faculty & Disclosure

Faculty

Frank Nyanin, PharmD

Accreditation

NA

Related Courses

2026 SPS Twin Cities | Hyaluronidase Delivering New Subcutaneous Dosage Forms Throughout Various Therapeutic Areas: A Dive into Clinical, Safety, Practice and Economic Considerations

2026 SPS Twin Cities | Hyaluronidase Delivering New Subcutaneous Dosage Forms Throughout Various Therapeutic Areas: A Dive into Clinical, Safety, Practice and Economic Considerations

0.00 Credits
1 Chapter
Pharmacology
Free
2026 SPS Twin Cities | CMS Drug Price Negotiations Through Maximum Fair Price (MFP): Access & Practice Considerations Now & Then

2026 SPS Twin Cities | CMS Drug Price Negotiations Through Maximum Fair Price (MFP): Access & Practice Considerations Now & Then

0.00 Credits
1 Chapter
Pharmacology
Free
Explore More Courses